Barron's Streetwise Andrew Bary’s Top Stocks for 2026
50 snips
Dec 19, 2025 In this engaging discussion, Andrew Bary, a Barron's columnist renowned for his stock expertise, shares his top stock picks for 2026 following a successful 2025. He dives into Amazon’s promising valuation amidst AI concerns, identifies Bristol-Myers as a value play with a strong dividend, and discusses Comcast's potential spinoff. Bary also highlights ExxonMobil’s solid fundamentals, Fairfax as a mini-Berkshire opportunity, and the growth prospects of Flutter’s FanDuel. Expect insights on undervalued gems like Disney and MSG Sports too!
AI Snips
Chapters
Transcript
Episode notes
Value Tilt With Select Growth Names
- Andrew Bary favors value-oriented picks this year over growth darlings from 2025.
- He believes quality growth names that lagged in 2025 can outperform in 2026.
Amazon Viewed As Reasonably Priced
- Amazon trades cheaply under 30 times 2026 earnings using conservative estimates including stock comp.
- Bary highlights AWS, e-commerce, advertising, and other emerging businesses as durable franchises.
Buy Cheap Pharma With Durable Yield
- Consider Bristol-Myers for yield and cheap valuation amid drug-sector winners and losers.
- Bary notes a nearly 5% dividend, P/E under 10, and an underappreciated pipeline including an Alzheimer's drug.